BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16483708)

  • 1. High non-protective, long-lasting antibody levels in malaria are associated with haplotype shifting in MHC-peptide-TCR complex formation: a new mechanism for immune evasion.
    Patarroyo ME; Bermúdez A; Salazar LM; Espejo F
    Biochimie; 2006 Jul; 88(7):775-84. PubMed ID: 16483708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides inducing short-lived antibody responses against Plasmodium falciparum malaria have shorter structures and are read in a different MHC II functional register.
    Patarroyo ME; Alba MP; Vargas LE; Silva Y; Rosas J; Rodríguez R
    Biochemistry; 2005 May; 44(18):6745-54. PubMed ID: 15865420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective cellular immunity against P. falciparum malaria merozoites is associated with a different P7 and P8 residue orientation in the MHC-peptide-TCR complex.
    Patarroyo ME; Salazar LM; Cifuentes G; Lozano JM; Delgado G; Rivera Z; Rosas J; Vargas LE
    Biochimie; 2006 Feb; 88(2):219-30. PubMed ID: 16126320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elongating modified conserved peptides eliminates their immunogenicity and protective efficacy against P. falciparum malaria.
    Espejo F; Bermúdez A; Vanegas M; Rivera Z; Torres E; Salazar LM; Patarroyo ME
    J Struct Biol; 2005 Jun; 150(3):245-58. PubMed ID: 15890273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fitting modified HRP-I peptide analogue 3D structure into HLA-DR molecules induces protection against Plasmodium falciparum malaria.
    Bermúdez A; Alba P; Espejo F; Vargas LE; Parra C; Rodríguez R; Reyes C; Patarroyo ME
    Int J Biochem Cell Biol; 2005 Feb; 37(2):336-49. PubMed ID: 15474979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing ABRA protein peptide to fit into the HLA-DRbeta1*0301 molecule renders it protection-inducing.
    Salazar LM; Alba MP; Curtidor H; Bermúdez A; Luis E Vargas ; Rivera ZJ; Patarroyo ME
    Biochem Biophys Res Commun; 2004 Sep; 322(1):119-25. PubMed ID: 15313182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.
    Patarroyo ME; Patarroyo MA
    Acc Chem Res; 2008 Mar; 41(3):377-86. PubMed ID: 18266328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR allele reading register shifting is associated with immunity induced by SERA peptide analogues.
    Salazar LM; Bermúdez A; Patarroyo ME
    Biochem Biophys Res Commun; 2008 Jul; 372(1):114-20. PubMed ID: 18482577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterisation of sporozoite components for a multistage, multi-epitope, anti-malarial vaccine.
    Patarroyo ME; Cifuentes G; Rodríguez R
    Int J Biochem Cell Biol; 2008; 40(3):543-57. PubMed ID: 17997122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orientating peptide residues and increasing the distance between pockets to enable fitting into MHC-TCR complex determine protection against malaria.
    Cifuentes G; Espejo F; Vargas LE; Parra C; Vanegas M; Patarroyo ME
    Biochemistry; 2004 Jun; 43(21):6545-53. PubMed ID: 15157087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying RESA protein peptide 6671 to fit into HLA-DRbeta1* pockets induces protection against malaria.
    Alba MP; Salazar LM; Vargas LE; Trujillo M; Lopez Y; Patarroyo ME
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1154-64. PubMed ID: 14985134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shortening and modifying the 1513 MSP-1 peptide's alpha-helical region induces protection against malaria.
    Espejo F; Bermúdez A; Torres E; Urquiza M; Rodríguez R; López Y; Patarroyo ME
    Biochem Biophys Res Commun; 2004 Mar; 315(2):418-27. PubMed ID: 14766224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence supporting the hypothesis that specifically modifying a malaria peptide to fit into HLA-DRbeta1*03 molecules induces antibody production and protection.
    Cifuentes G; Salazar LM; Vargas LE; Parra CA; Vanegas M; Cortes J; Patarroyo ME
    Vaccine; 2005 Feb; 23(13):1579-87. PubMed ID: 15694510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D structure determination of STARP peptides implicated in P. falciparum invasion of hepatic cells.
    Bermúdez A; Alba MP; Vanegas M; Patarroyo ME
    Vaccine; 2010 Jul; 28(31):4989-96. PubMed ID: 20580741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope of Plasmodium falciparum merozoite surface protein 1 displaying dimorphic amino acid polymorphism are highly constrained.
    Daubenberger CA; Nickel B; Ciatto C; Grütter MG; Pöltl-Frank F; Rossi L; Siegler U; Robinson J; Kashala O; Patarroyo ME; Pluschke G
    Eur J Immunol; 2002 Dec; 32(12):3667-77. PubMed ID: 12516559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and immunological analysis of circumsporozoite protein peptides: a further step in the identification of potential components of a minimal subunit-based, chemically synthesised antimalarial vaccine.
    Bermúdez A; Vanegas M; Patarroyo ME
    Vaccine; 2008 Dec; 26(52):6908-18. PubMed ID: 18930095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Based on HLA-DR beta1* allele binding specificities, striking differences in distance and TCR Contacting Residue Orientation can be observed in modified protection-inducing malarial synthetic peptides.
    Patarroyo ME; Cifuentes G; Salazar LM; Espejo F; Alba MP; Bermúdez A
    Curr Med Chem; 2005; 12(24):2849-65. PubMed ID: 16305475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins.
    Cifuentes G; Vanegas M; Martinez NL; Pirajan C; Patarroyo ME
    Biochem Biophys Res Commun; 2009 Jul; 384(4):455-60. PubMed ID: 19422790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distorting malaria peptide backbone structure to enable fitting into MHC class II molecules renders modified peptides immunogenic and protective.
    Cifuentes G; Patarroyo ME; Urquiza M; Ramirez LE; Reyes C; Rodriguez R
    J Med Chem; 2003 May; 46(11):2250-3. PubMed ID: 12747797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural modifications to a high-activity binding peptide located within the PfEMP1 NTS domain induce protection against P. falciparum malaria in Aotus monkeys.
    Curtidor H; Torres MH; Alba MP; Patarroyo ME
    Biol Chem; 2007 Jan; 388(1):25-36. PubMed ID: 17214546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.